BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 16863907)

  • 21. Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F-benzoyl-TN14003.
    Abraham M; Biyder K; Begin M; Wald H; Weiss ID; Galun E; Nagler A; Peled A
    Stem Cells; 2007 Sep; 25(9):2158-66. PubMed ID: 17525235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mobilization of peripheral blood progenitor cells by Betafectin PGG-Glucan alone and in combination with granulocyte colony-stimulating factor.
    Patchen ML; Liang J; Vaudrain T; Martin T; Melican D; Zhong S; Stewart M; Quesenberry PJ
    Stem Cells; 1998; 16(3):208-17. PubMed ID: 9617896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carboxypeptidase M expressed by human bone marrow cells cleaves the C-terminal lysine of stromal cell-derived factor-1alpha: another player in hematopoietic stem/progenitor cell mobilization?
    Marquez-Curtis L; Jalili A; Deiteren K; Shirvaikar N; Lambeir AM; Janowska-Wieczorek A
    Stem Cells; 2008 May; 26(5):1211-20. PubMed ID: 18292211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mobilized peripheral blood stem cells provide rapid reconstitution but impaired long-term engraftment in a mouse model.
    Yeoh JS; Ausema A; Wierenga P; de Haan G; van Os R
    Bone Marrow Transplant; 2007 Apr; 39(7):401-9. PubMed ID: 17293881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of hematopoietic stem cell mobilization: when innate immunity assails the cells that make blood and bone.
    Winkler IG; Lévesque JP
    Exp Hematol; 2006 Aug; 34(8):996-1009. PubMed ID: 16863906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates.
    Hematti P; Tuchman S; Larochelle A; Metzger ME; Donahue RE; Tisdale JF
    Stem Cells; 2004; 22(6):1062-9. PubMed ID: 15536196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of matrix metalloproteinase (MMP)-9 knockout mice demonstrates that MMP-9 activity is not absolutely required for G-CSF or Flt-3 ligand-induced hematopoietic progenitor cell mobilization or engraftment.
    Robinson SN; Pisarev VM; Chavez JM; Singh RK; Talmadge JE
    Stem Cells; 2003; 21(4):417-27. PubMed ID: 12832695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunologic profiles of effector cells and peripheral blood stem cells mobilized with different hematopoietic growth factors.
    Gazitt Y
    Stem Cells; 2000; 18(6):390-8. PubMed ID: 11072026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood.
    Dahl E; Burroughs J; DeFor T; Verfaillie C; Weisdorf D
    Bone Marrow Transplant; 2003 Sep; 32(6):575-80. PubMed ID: 12953129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.
    Petit I; Szyper-Kravitz M; Nagler A; Lahav M; Peled A; Habler L; Ponomaryov T; Taichman RS; Arenzana-Seisdedos F; Fujii N; Sandbank J; Zipori D; Lapidot T
    Nat Immunol; 2002 Jul; 3(7):687-94. PubMed ID: 12068293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF.
    Hill GR; Morris ES; Fuery M; Hutchins C; Butler J; Grigg A; Roberts A; Bradstock K; Szer J; Kennedy G; Morton J; Durrant S
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):603-7. PubMed ID: 16737933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small peptide analogs to stromal derived factor-1 enhance chemotactic migration of human and mouse hematopoietic cells.
    Zhong R; Law P; Wong D; Merzouk A; Salari H; Ball ED
    Exp Hematol; 2004 May; 32(5):470-5. PubMed ID: 15145215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells.
    Van Overstraeten-Schlögel N; Beguin Y; Gothot A
    Eur J Haematol; 2006 Jun; 76(6):488-93. PubMed ID: 16494621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid hematopoietic progenitor mobilization by sulfated colominic acid.
    Kubonishi S; Kikuchi T; Yamaguchi S; Tamamura H; Fujii N; Watanabe T; Arenzana-Seisdedos F; Ikeda K; Matsui T; Tanimoto M; Katayama Y
    Biochem Biophys Res Commun; 2007 Apr; 355(4):970-5. PubMed ID: 17335773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD34+ cell adhesion molecule profiles differ between patients mobilized with granulocyte-colony-stimulating factor alone and chemotherapy followed by granulocyte-colony-stimulating factor.
    Ford CD; Greenwood J; Anderson J; Snow G; Petersen FB
    Transfusion; 2006 Feb; 46(2):193-8. PubMed ID: 16441594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management strategies for poor peripheral blood stem cell mobilization.
    Moog R
    Transfus Apher Sci; 2008 Jun; 38(3):229-36. PubMed ID: 18485822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
    Elfenbein GJ; Sackstein R
    Exp Hematol; 2004 Apr; 32(4):327-39. PubMed ID: 15050742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose radiation (LDR) induces hematopoietic hormesis: LDR-induced mobilization of hematopoietic progenitor cells into peripheral blood circulation.
    Li W; Wang G; Cui J; Xue L; Cai L
    Exp Hematol; 2004 Nov; 32(11):1088-96. PubMed ID: 15539087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient transduction and engraftment of G-CSF-mobilized peripheral blood CD34+ cells in nonhuman primates using GALV-pseudotyped gammaretroviral vectors.
    Beard BC; Mezquita P; Morris JC; Kiem HP
    Mol Ther; 2006 Aug; 14(2):212-7. PubMed ID: 16631413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of the SDF-1-CXCR4 axis by the third complement component (C3)--implications for trafficking of CXCR4+ stem cells.
    Ratajczak MZ; Reca R; Wysoczynski M; Yan J; Ratajczak J
    Exp Hematol; 2006 Aug; 34(8):986-95. PubMed ID: 16863905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.